Published: Sep, 2016
The leading players operating in the global D-dimer testing market are Siemens Healthcare, Alere, Inc., and Abbott Laboratories. The cumulative share of these companies stood at 49.9% in 2013. The progress of these players will primarily depend on the intensifying research and development activities. Analysts anticipate that the highly fragmented market will witness a large number of new entrants in the coming years, making their way in the market with technologically advanced and user-friendly testing solutions.
The research report states that the opportunity in the global D-dimer testing market will be worth US$1.9 bn by 2022. The overall market is anticipated to be driven by the deep vein thrombosis as the segment progresses at a CAGR of 2.7% from 2014 to 2022. In terms of geography, the D-dimer testing methods will witness an increased adoption in North America driving the region to contribute nearly US$917.1 mn by 2022. A strong presence of the point of care testing methods and laboratory-based D-dimer tests will provide a boost to this market in North America in the coming years.
High Prevalence of CVD Drives Uptake of D-dimer Testing Methods
The high incidence of cardiovascular diseases (CVD) is likely to be the prime cause of increasing demand for D-dimer testing methods in the near future. Effective disease management will require improved indicators, which will minimize the cost of treating cardiovascular diseases, strokes, and attacks. Thus, players in the D-dimer market are focusing on developing tests that will help in early diagnosis of CVD, an effort that will pick up the pace in the coming years.
The global D-dimer testing market is also being driven by increasing number of deep vein thrombosis patients being treated through anti-coagulation therapy. Patients suffering from cerebral artery disease or coronary disease also require this therapy, which had led to a rise in the demand for coagulometers and related reagents. Owing to this reason, several patients require point of care (POC) testing to ensure they corroborate with central coagulation laboratory results.
Inaccuracy of POC Challenges Market Growth
Despite the strong market drivers, the global D-dimer testing market is being held back due to the discrepancies in interpreting D-dimer values as the values naturally increase for the elderly, thereby decreasing its accuracy for embolism. However, overcoming this restraint by designing age-adjusted D-dimer testing models to eliminate DVT and pulmonary embolism (PE) has created a new opportunity for the manufacturers in the global market.
The lack of acceptance of D-dimer testing for point of care testing is a tough challenge for this market. Health care providers are still skeptical towards accepting D-dimer testing as a valid method of testing due to the inaccuracy in results as compared to laboratory testing. Thus, its usefulness in clinics, convenience, and cost of higher adoption still remains under question.
“Players need to focus on bioinformatics and integrated software for precise multiple factor analysis all throughout standardized runs,” states the lead author of research report. Furthermore, it would also ensure quality control in the longer-run. Manufacturers must also focus on implementing rapid diagnostic testing to solve the issue of overcrowding in emergency departments, which has become a threat to the public health. Identifying the popularly used tests, improving their levels of accuracy in POC testing methods, and narrowing down on their impact on the patient outcomes will revolutionize the management of overcrowding in emergency departments. This, in turn, will help avert unnecessary cost of laboratory services and spread of diseases.
The aforementioned review is based on Transparency Market Research’s report, titled “D-dimer Testing Market - Global Industry Analysis, Size, Share, Volume, Growth, Trends and Forecast 2014 – 2022.”
The global D-dimer Testing Market is segmented as follows:
- Global D-dimer Testing Market Revenue (USD Million) and Volume (Number of Tests), by Testing Method
- Point-of-Care Tests
- Laboratory Tests
- Coagulation Analyzers
- Clinical Chemistry Analyzers
- Global D-dimer Testing Market Revenue (USD Million) and Volume (Number of Tests), by Applications
- Deep Vein Thrombosis
- Pulmonary Embolism
- Disseminated Intravascular Coagulation
- Global D-dimer Testing Market Revenue (USD Million) and Volume (Number of Tests), by Geography
- North America
- Rest of Europe
- Asia Pacific
- Rest of Asia Pacific
- Latin America (LATAM)
- Rest of Latin America
- Middle East and North Africa (MENA)
- Saudi Arabia
- United Arab Emirates (U.A.E)
- Rest of MENA
- Rest of the World (RoW)
- North America
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
US Office Contact
90 State Street, Suite 700
Albany, NY 12207
USA - Canada Toll Free: 866-552-3453